The COVID-19 pandemic highlighted healthcare disparities in multiple countries. As such
morbidity and mortality vary significantly around the globe between populations and ethnic …

Coronavirus disease 2019 (COVID-19) shows a wide variation in expression and severity of
symptoms, from very mild or no symptoms, to flu-like symptoms, and in more severe cases …

Background. The viral spike (S) protein and host ACE2 and TMPRSS2 genetic variations
may act as a barrier to viral infections or determine susceptibility to severe acute respiratory …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is at present an
emerging global public health crisis. Angiotensin converting enzyme 2 (ACE2) and trans …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved to display
particular patterns of genetic diversity in the genome across geographical regions. These …

Introduction: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has spread
around the globe. Susceptibility has been associated with age, biological sex, and other …

The contribution of human genes to the variability of disease outcomes has been shown to
be important across infectious diseases. Studies have shown mutations within specific …

There is considerable variability in the susceptibility and progression for COVID-19 and it
appears to be strongly correlated with age, gender, ethnicity and pre-existing health …

Abstract The World Health Organization recently announced that pandemic status has been
achieved for coronavirus disease 2019 (COVID-19), which is caused by severe acute …

Heterogeneity in symptoms associated with COVID‐19 in infected patients remains unclear.
ACE2 and TMPRSS2 gene variants are considered possible risk factors for COVID‐19. In …